Structured Abstract
Importance Preeclampsia poses a significant threat to women’s long-term health. However, what diseases are affected and at what level they are affected by PE needs a thorough investigation.
Objective To conduct the first large-scale, non-hypothesis-driven study using EHR data from multiple medical centers to comprehensively explore adverse health outcomes after preeclampsia
Design Retrospective multi-cohort case-control study
Participants We analyzed 3,592 preeclampsia patients and 23,040 non-preeclampsia controls from the University of Michigan Healthcare System. We externally validated the findings using UK Biobank data (443 cases, 14,870 controls) and Cedar Sinai data(2755 cases, 60,305 controls).
Main outcomes We showed that six complications are significantly affected by PE. We demonstrate the effect of race as well as preeclampsia severity on these complications.
Results PE significantly increases the risk of later hypertension, uncomplicated and complicated diabetes, renal failure and obesity, after careful confounder adjustment. We also identified that hypothyroidism risks are significantly reduced in PE patients, particularly among African Americans. Severe PE affects hypertension, renal failure, uncomplicated diabetes and obesity more than mild PE, as expected. Caucasians are affected more negatively than African Americans by PE on future hypertension, uncomplicated and complicated diabetes and obesity.
Conclusion This study fills a gap in the comprehensive assessment of preeclampsia’s long-term effects using large-scale EHR data and rigorous statistical methods. Our findings emphasize the need for extended monitoring and tailored interventions for women with a history of preeclampsia, by considering pre-existing conditions, preeclampsia severity, and racial differences.
Question Which complications are more or less likely to occur in patients after preeclampsia (PE), compared to those with normal pregnancies? How do the severity of PE and patient race further affect these complications?
Findings In a retrospective case-control study on 3 datasets (n = 26,632, n = 15,313, n= 63,060), we identified 5 complications with significantly increased risk due to PE, including hypertension, uncomplicated and complicated diabetes, renal failure and obesity, after careful confounder adjustment. We also identified that hypothyroidism risks are reduced in PE patients, particularly significant among African Americans. Severe PE affects hypertension, renal failure, uncomplicated diabetes and obesity more than mild PE, as expected. Caucasians are affected more negatively than African Americans by PE on future hypertension, uncomplicated and complicated diabetes and obesity.
Meaning Patients with a history of PE should be closely monitored and carefully assessed for the risks of developing these complications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
XY is supported by T32GM141746 fellowship by NIGMS. LXG is supported by grants by NIH/NIGMS, R01 LM012373 and R01 LM012907 awarded by NLM, and R01 HD084633 awarded by NICHD. WX and RL are supported by the Neurology Collaborative Pilot Funding Awards awarded by Cedars-Sinai Medical Center.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the University of Michigan gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
added new validation results from Cedars-sinai phi dataset. added the effect of PE severity on long-term complications
Data Availability
The EHR data from the University of Michigan Precision Health and Cedar-Sinai limited PHI contains sensitive patient information and cannot be made public. Researchers meeting the criteria for using sensitive data may contact the Research Scientific Facilitators at the University of Michigan Precision Health by emailing PHDataHelp{at}umich.edu or visiting https://research.medicine.umich.edu/our-units/data-office-clinical-translational-research/data-access for more information about requesting data access. For Cedars-Sinai limited PHI data, interested researchers may contact inquiries via: Groupeisherbcommittee{at}cshs.org. UK biobank clinical data are available through the application approval on https://www.ukbiobank.ac.uk/
Abbreviations
- PE
- preeclampsia
- HER
- electronic health record
- UMich
- University of Michigan
- IRB
- Institutional Review Board
- ICD
- International Classification of Diseases
- OR
- odds ratio
- CI
- confidence interval
- VIF
- Variance Inflation Factor
